To start GH replacement therapy, the diagnosis of patients with PWS without any confirmatory test is sufficient, while it is necessary to perform dynamic tests after the attainment of final height as the deficit is often not confirmed in adulthood [13]
further explored the relationship between GLP-1 receptor agonists and thyroid disorders, providing broader evidence that the risk of common thyroid dysfunctions is not significantly elevated by these treatments
A Case Report on Semaglutide and Persistent Hiccups. Journal of Clinical Endocrinology & Metabolism , Year)
"The most striking finding is direct evidence that a person's DNA directly shapes how their body responds to GLP-1 weight-loss medications," study co-author Adam Auton, vice president of human genetics at 23andMe Research Institute, told Newsweek in an email
Yes, it may take some trial and error to get there